Advertisement News Archives - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

News

December 2, 2021

Sanofi agrees to buy Austria-based Origimm Biotechnology

Sanofi has signed an agreement to buy Origimm Biotechnology, an Austria-based privately owned biotechnology company with focus on virulent skin microbiome components and antigens from bacteria causing skin disease.

Sanofi agrees to buy Austria-based Origimm Biotechnology